Alight, Inc. (NYSE:ALIT) is one of the 10 Best US Penny Stocks to Buy. On December 19, Needham reiterated its Buy rating on Alight, Inc. (NYSE:ALIT) but lowered its price target from $4.5 to $3.5 on ...

Alight is initiated at a sell rating due to declining revenue, customer attrition, and poor competitive positioning in the benefits enrollment software space. ALIT faces a -3% to -4% revenue decline ...

Offers integrated digital human capital and business solutions, including benefits administration, healthcare navigation, financial health, payroll, and cloud-based professional services. Generates ...

Video editing Mac users can efficiently produce professional-looking content on a MacBook Air thanks to iMovie's intuitive interface and the hardware acceleration of M-series chips. Beginners benefit ...

Investing.com - DA Davidson has reiterated its Buy rating and $6.00 price target on Alight Solutions (NYSE:ALIT) following Starboard Value’s complete exit from its position in the company. The firm’s ...

Investors who take an interest in Alight, Inc. (NYSE:ALIT) should definitely note that the Independent Director, Richard Massey, recently paid US$2.33 per share to buy US$233k worth of the stock.

Alight is parting ways with Dave Guilmette, its chief executive and vice chairman, and has hired Crawford & Co. executive Rohit Verma to take the helm of the cloud-based human capital technology and ...

Dave Guilmette, CEO of benefits solutions provider Alight, will step down at the end of the year and be replaced by Rohit Verma, who currently leads Crawford & Company, which provides insurance claims ...

Alight, Inc. (NYSE: ALIT) (the "Company”), a leading cloud-based human capital and technology-enabled services provider, announced that the Company's Board of Directors (the “Board”) has appointed ...

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we treat hundreds of genetic diseases. By fine-tuning the tiny molecular “tools ...